Anti-depressants Flashcards

1
Q

What is important to remember about Lithium

A

Strictly, it is not an anti-depressant

It is a mood stabilising drug.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Summarise ECT

A

Used in cases of ‘black depression’- where the patient is not responding to talking therapies or drugs
Current across temporal lobe
Give a shot of suxamethonium short-acting NMJ blocker- to prevent any damage to the limbs from convulsions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the different classification of psychoses

A
Split into:
Schizophrenia (thought disorders)
Affective disorders (mood-related)- which consist of mania (less common) and depression.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the emotional (psychological) symptoms of depression

A

Misery, apathy, pessimism

Low self-esteem

Loss of motivation

Anhedonia (inability to enjoy life)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the biological (somatic) symptoms of depression

A

Slowing of thought & action (psychomotor retardation)

Loss of libido

Loss of appetite, sleep disturbance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the two different types of depression

A

Unipolar depression/ depressive disorder

Bipolar depression/ Manic Depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe unipolar depression / depressive disorder

A

Mood swings in same direction

Relatively late onset

Reactive depression (75%) - stressful life events (disproportionate response)

	- non-familial
Endogenous depression (25%) 	- unrelated to external
			stresses
	- familial pattern
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is important to remember about the drug treatment for unipolar depression

A

Same for both reactive and endogenous depression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe bipolar depression

A

Oscillating depression/mania

Less common; Early adult onset

Strong hereditary tendency

Drug treatment (Lithium- oral lithium carbonate- effects I.C secondary messenger symtpoms (reduces cAMP and IP3)

Symptoms of mania- opposite to that of depression (increased exuberance, aggression etc).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the key difference between bipolar depression and unipolar depression

A

Bipolar depression- symptoms in common with schizophrenia

Unipolar depression- symptoms associated with fear and aggression.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define what is meant by ‘psychoses’

A

Severe mental disorders, with or without, organic damage, characterised by derangement of personality and loss of contact with reality, and causing deterioration of normal social functioning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the monamine theory of depression

A

§ Monoamine theory of depression – depression is a functional deficit of central MA transmission; Mania is a functional excess of MA transmission.
o Related to NA and 5-HT (serotonin) deficits/excesses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Summarise the pharmacological evidence that supports the monamine theory of depression

A

TCAs- block NA and 5-HT reuptake- Increase MOOD
MA oxidase inhibitors – Increase stores of NA and 5-HT – increase MOOD
Reserpine (MA deplete) - inhibits NA and 5-HT storage - decreases mood
a-methyltyrosine and methyldopa- inhibit NA synthesis- decreasing mood (and calming of manic patients)
ECT- increases CNS response to NA and 5-HT- increases mood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the pharmacological evidence that disagrees with the monoamine theory of depression.

A

Amphetamine- releases NA and blocks re-uptake- no effect on mood (but causes euphoria in normal subjects).
Cocaine- inhibits NA reuptake- no effect on mood (but causes euphoria in normal subjects)
Tryptophan -increases 5-HT synthesis- mood may increase in some subjects but not all
Alpha and beta adrenoreceptor antagonists - block NA action- mood slightly reduced, but no effect on manic patients
Methysegide- 5-HT antagonist- no effect
L-dopa - increases NA synthesis - no effect
Iprindole- no effect on monamine metabolism- increases mood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the inconsistency of the biochemical evidence of the monamine theory

A

Although a reduction of NA metabolites are seen in patients with clinical depression, there is no correlation i.e not necessarily an even greater reduction in NA metabolites for a patient with severe depression as opposed to mild depression.
There is a delayed onset of the clinical effects of drugs, when the reduction in monamines would take place acutely. This may be due to adaptive changes of the neurones of depressed patients (i.e down regulation of a2, beta and 5-HT receptors) which are only targeted by anti-depressants after a couple of weeks.

However the general conclusions remain firm- and many of the anti-depressants target monamine metabolism to have their effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe some other theories for depression

A
HPA axis (↑ CRH levels)?- 
Hippocampal neurodegeneration? - anti-depressant drugs have been shown to reverse this. 

The plasma cortisol concentration is usually high in depressed patients. Other hormones in plasma are also affected, for example, growth hormone concentration is reduced and prolactin is increased. While these changes are consistent with deficiencies in monoamine transmission, they are not specific to depressive syndromes.
But CRF1 receptor antagonists have not been effective.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why may cocaine not be effective in treating depression

A

Adaptive changes of neurones in depressed patients- may not express cocaine receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe Reserpine

A

Originally licenced as an anti-hypertensive- no longer used due to its association with depression.
Monamine depletor- that is it inhibits the synaptic proteins that package and store NA in vesicles- depleting its storage- less released.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Give an example of a TCA

A

amitriptyline

20
Q

Summarise the chemical structures of TCAs

A

All have a tri-cyclic structure
Fall into two types:
Dibenzazepines
Dibenzcycloheptenes (amitriptyline).

21
Q

Describe the mechanism of action of TCAs

A

Neural monamine reuptake inhibitors- effect NA and 5-HT roughly equally- but different TCAs have variable selectivity- inhibiting reuptake will acutely facilitate the transmission of monamines
Also acts on other receptors:
. § a2 – block pre-synaptic inhibition of NA release and 5-HT release). - this would contribute to anti-depressant actions
§ mAChR.
§ H2 (histamine) receptors.
§ 5-HT receptors

22
Q

Explain the delayed effects of TCAs

A

Delayed down-regulation of β-adrenoceptors & 5-HT2 receptors, also A2 receptors.
Dysregulated, down-regulated to normal levels which allows them to function normally.

23
Q

Describe the pharmacokinetics of TCAs

A

o Oral administration (rapid oral absorption)
o Highly PPB – 90-95%.
o Hepatic metabolism (liver microsomal enzymes) – to ACTIVE metabolites (with weak TCA like activity) à excreted in the urine (glucuronide conjugates).
o Plasma T1/2 = 10-20 hours – dose once daily.

24
Q

Describe the unwanted effects of TCAs at a therapeutic dose

A
Atropine - like effects (amitriptyline)- muscarinic receptor block (Sedation
Anticholinergic effects (dry mouth, constipation, blurred vision, urinary retention, etc)

Postural hypotension (vasomotor centre)- blocks a2 receptors

Sedation (H1 antagonism) - may be useful if taken late at night- depression can hinder sleep quality and pattern.

25
Q

Describe the acute toxic effects of TCAs due to overdose

A

CNS: excitement, delirium, seizures  coma,
respiratory depression

CVS: cardiac dysrhythmias  ventricular
fibrillation/sudden death (anti-muscarinic effects and increased NA effects on heart).

Care - attempted suicide

26
Q

Describe the drug interactions of TCAs

A

PPB:  TCA effects (aspirin, phenytoin) - aspirin-50% PPB- compete for same binding site- increasing conc of TCAs- toxic effects

Hepatic microsomal enzymes:  TCA effects (neuroleptics; oral contraceptives)- compete for metabolism- TCA broken down more slowly- increasing toxicity

Potentiation of CNS depressants (alcohol)- additive effect with alcohol

Antihypertensive drugs (monitor closely) - sometimes BP goes up, sometimes it goes down- just monitor it initially.

27
Q

Give an example of a monamine oxidase inhibitor

A

Phenelzine

28
Q

Describe the mechanism of action of MAOIs

A

§ Mechanism of action:
o MAO enzymes:
§ MAO-A breaks down NA & 5-HT – key MoA!
§ MAO-B: breaks down DA – e.g. Selegiline.
o Most are non-selective MAOIs.
o Irreversible inhibition leads to a long duration of action.

We are trying to develop drugs which selectively target the MAO-A, MAO-B inhibitors are important in Parkinson’s.

29
Q

What is the main function of MAO

A

1.
Within nerve terminals, MAO regulates the free intraneuronal concentration of noradrenaline or 5-HT. It is not involved in the inactivation of released transmitter.
2.
MAO in the gut wall is important in the inactivation of endogenous and ingested amines such as tyramine that would otherwise produce unwanted effects.

30
Q

Describe the effects of MAOIs

A

§ Rapid effects – increase cytoplasmic (not enhanced release but more leakage) NA, 5-HT.
§ Delayed effects – delayed clinical response due to down-regulation of b-adrenoceptors and 5-HT2 receptors – again, fits with delayed clinical effect.
o Inhibits other enzymes – leads to side effects.

Slow the breakdown of monamines.
MAOI crosses BBB, reaches noradrenaline and serotinergic pre-synaptic terminals- inhibit MAO- increasing cytoplasmic conc of NA and 5-HT- thus increasing its release (mostly leakage) and transmission.

31
Q

Summarise the structure of TCAs

A

Single ring- with reactive side chain:
Hydrazines (Phenelzine)
Cyclopropylamines
Proprygylamines

Clorygyline is MOA-A specific and used to treat depression.

32
Q

Describe the pharmacokinetics of MOAIs

A

Rapid oral absorption

Short plasma t1/2 (few hrs) but longer d.o.a.- they irreversibly bind (covalently with reactive side chain) to (and thus inactivate) monamine oxidase.

Metabolised in liver; excreted in urine

33
Q

Describe the unwanted effects of MOAIs

A

Atropine - like effects (< TCAs)

Postural hypotension (common)- effects on vasomotor centre. One possible explanation for this effect – the opposite of what might have been expected – is that amines such as dopamine or octopamine accumulate within peripheral sympathetic nerve terminals and displace noradrenaline from the storage vesicles, thus reducing noradrenaline release associated with sympathetic activity.

Sedation (Seizures in o.d.)

Weight gain (possibly excessive)- due to increase appetite.

Hepatotoxicity (hydrazines; rare) - due to reactive side chains- don’t prescribe to patients with liver problems

34
Q

Describe the drug interactions associated with MAOIs

A

‘Cheese reaction’: Tyramine-containing foods + MAOI  hypertensive crisis (throbbing headache,  b.p., intracranial haemorrhage)

MAOIs + TCAs  hypertensive episodes (avoid)

MAOIs + pethidine  hyperpyrexia, restlessness, coma & hypotension- pethidine is a opioid analgesic- maybe that they are metabolised by the same enzyme- forcing pethidine into methabolism by a different enzyme- which results in the production of toxic metabolites.

35
Q

Describe the ‘cheese’ reaction

A

Tyramine found in foods such as marmite, game, red wine and cheese.
Tyramine is normally digested by MOA-B in the gut wall
However if we inhibit MOA-B, we get a build up of tyramine
Tyramine, like amphetamine, is a sympathomimetic. That is, it increases the release of NA from post-ganglionic pre-synaptic nerve terminals (binds to the vesicles containing NA- facilitating their release) -hence we get hypertension seen.

36
Q

Describe the reversible MAOI inhibitors

A

Moclobemide: reversible MAO-A inhibitor (RIMA). ↓ Drug interactions ↓ doa.

The irreversible MAOIs have been shown to be more efficacious.

37
Q

Give an example of an SSRI

A

Fluoxetine

38
Q

Describe the structure of Fluoxetine

A

2 cyclical rings with an aliphatic chain.

39
Q

Describe the pros and cons of SSRIS

A

Less troublesome side-effects; safer in o.d.- no cheese reaction

But less effective vs severe depression - so still need other drugs

40
Q

Describe the pharmacokinetics of SSRIs

A

p.o. administration

Plasma t1/2 (18-24 hrs)

Delayed onset of action (2-4 weeks)

Fluoxetine competes with TCAs for hepatic enzymes (avoid co-administration) - otherwise the two will potentiate and you will see toxic effects.

41
Q

Describe the unwanted effects of SSRIs

A

Fewer than TCAs/MAOIs

Nausea, diarrhoea, insomnia & loss of libido

Interact with MAOIs (avoid co-administration

42
Q

What is important to remember about SSRIs

A

Fluoxetine (‘Prozac’): currently most prescribed antidepressant drug
No effective in all patients- so need to use other anti-depressants.

43
Q

Describe Venlafaxine

A

Venlafaxine: Dose-dependent Reuptake inhibitor
5HT > NA&raquo_space; DA (SNRI)- serotonin,noradrenaline reuptake inhibitor
2nd Line treatment for severe depression

44
Q

Describe Mirtazapine

A

Mirtazapine: α2 Receptor antagonist
↑ NA & 5HT release- inhibit negative feedback.
Other R interactions (sedative)- Histamine receptors
Useful in SSRI-intolerant patients

45
Q

What can lithium be used to treat

A

Inorganic ion taken orally as lithium carbonate- used to control mania as well as depression- mainly used prophylactically in bipolar depression.
Long plasma half-life and narrow therapeutic window, hence side effects common and monitoring of plasma concentration is essential.
Unwanted effects: nausea, thirst and polyuria, hypothyroidism, tremor, weakness, mental confusion, teratogenesis.
Acute overdose causes confusion, convulsions and cardiac dysrrythmias.
Action enhanced by diuiretic drugs.
Alternative mood-stabilisers include carbamazepine, valproate.